The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Abstract
After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [149]
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [55]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation
Research works printed but not linked: 13
- Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
- Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
- Powell S. N., et al., Cancer Res. 55, 1643 (1995);
- Fan S., et al., Cancer Res. 55, 1649 (1995);
- Russell K. J., et al., ibid. 55, 1639 (1995).
- Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
- Michieli P., et al., Cancer Res. 54, 3391 (1994);
- Paules R. S., et al., Cancer Res 55, 1763 (1995);
- Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
- Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
- Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
- El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
- Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);
Cited by
Sorted by citations
Items 401–500 of 1,018
Can graphene quantum dots cause DNA damage in cells?
Wang, D., Zhu, L. H., Chen, J., & Dai, L. (2015) · Nanoscale · doi:10.1039/c5nr01734c · Cited by 128
Ito, E., Yip, K. W., Katz, D., Fonseca, S. B., Hedley, D. W., Chow, S., Xu, G., Wood, T. E., Bastianutto, C., Schimmer, A. D., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055277 · Cited by 128
Bruno, T., Nicola, F. D., Iezzi, S., Lecis, D., D’Angelo, C., Padova, M. D., Corbi, N., Dimiziani, L., Zannini, L., Jekimovs, C., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.012 · Cited by 132
Huang, J. M., Li-jun, W., Tashiro, S., Onodera, S., & Ikejima, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08044fp · Cited by 127
Rau, B., Sturm, I., Lage, H., Berger, S. M., Schneider, U., Hauptmann, S., Wust, P., Riess, H. B., Schlag, P. M., Dörken, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.077 · Cited by 127
Yamaguchi, H., Chen, J., Bhalla, K. N., & Wang, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401530200 · Cited by 128
HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53Preprint
Sasaki, T., Gan, E. C., Wakeham, A. C., Kornbluth, S. A., Mak, T. W., & Okada, H. (2007) · Genes & Development · doi:10.1101/gad.1534107 · Cited by 130
Immortalisation and transformation revisited
Drayton, S. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00271-4 · Cited by 129
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 135
Hu, F., Gartenhaus, R. B., Eichberg, D. G., Liu, Z., Fang, H.-B., & Rapoport, A. P. (2010) · Oncogene · doi:10.1038/onc.2010.275 · Cited by 125
Requirement of Krüppel-like Factor 4 in Preventing Entry into Mitosis following DNA Damage
Yoon, H. S., & Yang, V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307631200 · Cited by 130
Tian, H., Wittmack, E. K., & Jorgensen, T. J. (2000) · PubMed · Cited by 125
Sengupta, S., & Wasylyk, B. (2001) · Genes & Development · doi:10.1101/gad.202201 · Cited by 130
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Shi, Y., Felley‐Bosco, E., Marti, T. M., Orlowski, K., Pruschy, M. N., & Stahel, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-571 · Cited by 124
Shi, L., Jackstadt, R., Siemens, H., Li, H., Kirchner, T., & Hermeking, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2203 · Cited by 125
Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells.
Gomathinayagam, R., Srinivasan, S., Mardhatillah, F., Kumar, R., Akbarsha, M. A., & Damodaran, C. (2008) · PubMed · Cited by 124
Umansky, C., Morellato, A. E., Scheidegger, M., Rieckher, M., Martinefski, M., Fernández, G. A., Kolesnikova, K., Vesting, A. J., Karakasilioti, I., Reingruber, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28242-7 · Cited by 126
Hockley, S. L., Arlt, V. M., Brewer, D. S., Giddings, I., & Phillips, D. H. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-260 · Cited by 131
Mitochondrial impairment in p53-deficient human cancer cells
Zhou, S. (2003) · Mutagenesis · doi:10.1093/mutage/18.3.287 · Cited by 130
Self-citationSmith, F. M., Reynolds, J. V., Miller, N., Stephens, R. B., & Kennedy, M. J. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.09.010 · Cited by 125
Trichinella spiralis: nurse cell formation with emphasis on analogy to muscle cell repair
Wu, Z., Sofronić‐Milosavljević, L., Nagano, I., & Takahashi, Y. (2008) · Parasites & Vectors · doi:10.1186/1756-3305-1-27 · Cited by 123
Ciciarello, M., Mangiacasale, R., Casenghi, M., Limongi, M. Z., D'Angelo, M., Soddu, S., Lavia, P., & Cundari, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009528200 · Cited by 123
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
Wang, C., Jette, N., Moussienko, D., Bebb, D. G., & Lees‐Miller, S. P. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.007 · Cited by 125
Qiao, C. U. I., Yu, J., Wu, J.-N., Tashiro, S., Onodera, S., Minami, M., & Ikejima, T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00588.x · Cited by 122
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
Takahashi, T., Haruki, N., Nomoto, S., Masuda, A., Saji, S., Osada, H., & Takahashi, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202807 · Cited by 122
How protein kinases co-ordinate mitosis in animal cells
Ma, H. T., & Poon, R. Y. C. (2011) · Biochemical Journal · doi:10.1042/bj20100284 · Cited by 126
Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status
Magrini, R., Bhonde, M., Hanski, M., Notter, M., Scherübl, H., Boland, C. R., Zeitz, M., & HANSKI, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10565 · Cited by 121
Piekorz, R. P., Hoffmeyer, A., Duntsch, C. D., McKay, C., Nakajima, H., Sexl, V., Snyder, L., Rehg, J. E., & Ihle, J. N. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.653 · Cited by 121
The T‐box transcription factor Tbx2: Its role in development and possible implication in cancer
Abrahams, A., Parker, M. I., & Prince, S. (2009) · IUBMB Life · doi:10.1002/iub.275 · Cited by 123
Curman, D., Cinel, B., Williams, D. E., Rundle, N. T., Block, W. D., Goodarzi, A. A., Hutchins, J. R. A., Clarke, P. R., Zhou, B.-B., Lees‐Miller, S. P., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100728200 · Cited by 121
Hu, G., Mancl, M. E., & Barnes, B. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0583 · Cited by 121
A common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 124
p53 tumor suppressor protein regulates the levels of huntingtin gene expression
Feng, Z., Jin, S. V., Zupnick, A., Hoh, J., de Stanchina, E., Lowe, S. W., Prives, C. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209021 · Cited by 125
Ye, X., Yue, W., Nalepa, G., & Harper, J. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8586-8600.2003 · Cited by 120
Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
Mirzayans, R., Andrais, B., Scott, A., Wang, Y., & Murray, D. L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122409 · Cited by 127
Basit, A., Cho, M.-G., Kim, E.-Y., Kwon, D., Kang, S., & Lee, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0416-y · Cited by 124
Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects
Xu, W., Perez, G., Ngo, L., Gui, C.-Y., & Marks, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4608 · Cited by 119
YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth
Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J. L., Reid, G., Woolley, A. G., Miller, L. D., Black, M. A., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr512 · Cited by 121
Pfau, R., Tzatsos, A., Kampranis, S. C., Serebrennikova, O. B., Bear, S. E., & Tsichlis, P. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711865105 · Cited by 119
DNA repair and aging: The impact of the p53 family
Nicolai, S., Rossi, A., Di Daniele, N., Melino, G., Annicchiarico-Petruzzelli, M., & Raschellà, G. (2015) · Aging · doi:10.18632/aging.100858 · Cited by 118
Marra, N. J., Stanhope, M. J., Jue, N. K., Wang, M., Sun, Q., Bitar, P. P., Richards, V. P., Komissarov, A. S., Rayko, M., Kliver, S. F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819778116 · Cited by 123
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 118
Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules
Xu, L., & Blackburn, E. H. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408181 · Cited by 121
Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1
Huang, S., Schönthal, A. H., & Stallcup, M. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204298 · Cited by 118
Houghton, J. A. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00008 · Cited by 118
de la Cruz-Morcillo, M. A., Valero, M. L. L., Callejas-Valera, J. L., Arias-González, L., Melgar-Rojas, P., Galán-Moya, E. M., García-Gil, E., García-Cano, J., & Sánchez-Prieto, R. (2012) · Oncogene · doi:10.1038/onc.2011.321 · Cited by 117
Retractedp53-dependent repression of polo-like kinase-1 (PLK1)
McKenzie, L., King, S., Marcar, L., Nicol, S., Dias, S. S., Schumm, K., Robertson, P., Bourdon, J., Perkins, N. D., Fuller-Pace, F. V., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13532 · Cited by 120
Gowrikumar, S., Palanivel, C., Manikandan, R., & Sudhandiran, G. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.013 · Cited by 118
Eymin, B., Leduc, C., Coll, J., Brambilla, E. M., & Gazzéri, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206303 · Cited by 117
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Wu, H., Pomeroy, S. L., Ferreira, M., Teider, N., Mariani, J., Nakayama, K. I., Hatakeyama, S., Tron, V. A., Saltibus, L. F., Spyracopoulos, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2283 · Cited by 120
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
Xia, M., & Land, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1208 · Cited by 120
Gmeiner, W. H., & Okechukwu, C. C. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.136 · Cited by 123
Zhou, J., Lu, G., Ong, C.-S., Ong, C. N., & Shen, H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0071 · Cited by 116
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 116
Pappa, G., Lichtenberg, M., Iori, R., Barillari, J., Bartsch, H., & Gerhäuser, C. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.01.007 · Cited by 116
Motwani, M., Jung, C. P., Sirotnak, F. M., She, Y., Shah, M. A., Gönen, M., & Schwartz, G. K. (2001) · PubMed · Cited by 116
The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
Gartel, A. L. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.023 · Cited by 116
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G. S., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 115
Wang, M., Morsbach, F., Sander, D., Gheorghiu, L., Nanda, A., Benes, C. H., Kriegs, M., Krause, M., Dikomey, E., Baumann, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0213 · Cited by 117
Waku, T., Nakajima, Y., Yokoyama, W., Nomura, N., Kako, K., Kobayashi, A., Shimizu, T., & Fukamizu, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.183723 · Cited by 115
p53 and Cell Cycle Effects After DNA Damage
Senturk, E., & Manfredi, J. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_4 · Cited by 115
The Paramyxovirus Simian Virus 5 V Protein Slows Progression of the Cell Cycle
Lin, G., & Lamb, R. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9152-9166.2000 · Cited by 115
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Wu, Z., Li-jun, W., Lin-hao, L., Tashiro, S., Onodera, S., & Ikejima, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.166 · Cited by 114
Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology
McKinley, E. T., Ayers, G. D., Smith, R. A., Saleh, S., Zhao, P., Washington, M. K., Coffey, R. J., & Manning, H. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058938 · Cited by 114
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Chen, X., Low, K.-H., Alexander, A., Jiang, Y., Karakaş, C., Hess, K. R., Carey, J. P. W., Bui, T. N., Vijayaraghavan, S., Evans, K. W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1446 · Cited by 118
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 117
Wang, Z., Kyo, S., Takakura, M., Tanaka, M., Yatabe, N., Maida, Y., Fujiwara, M., Hayakawa, J., Ohmichi, M., Koike, K., et al. (2000) · PubMed · Cited by 116
Dunne, P. D., McArt, D. G., Blayney, J. K., Kalimutho, M., Greer, S., Wang, T., Srivastava, S., Ong, C. W., Arthur, K., Loughrey, M. B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1354 · Cited by 113
Tsuchiya, N., Izumiya, M., Ogata‐Kawata, H., Okamoto, K., Fujiwara, Y., Nakai, M., Okabe, A., Schetter, A. J., Bowman, E. D., Midorikawa, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2475 · Cited by 120
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Sansregret, L., Patterson, J. O., Dewhurst, S. M., López‐García, C., Koch, A., McGranahan, N., Chao, W. C. H., Barry, D. J., Rowan, A., Instrell, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0645 · Cited by 117
Iakovou, E., & Kourti, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.827900 · Cited by 119
Classification of Heavy-Metal Toxicity by Human DNA Microarray Analysis
Kawata, K., Yokoo, H., Shimazaki, R., & Okabe, S. (2007) · Environmental Science & Technology · doi:10.1021/es062717d · Cited by 113
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background
Fang, Y., Tsao, C., Goodman, B. K., Furumai, R., Tirado, C. A., Abraham, R. T., & Wang, X.-F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600315 · Cited by 115
14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 116
Human single-stranded DNA binding proteins are essential for maintaining genomic stability
Ashton, N. W., Bolderson, E., Cubeddu, L., O'Byrne, K. J., & Richard, D. J. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-9 · Cited by 118
Involvement of the INK4a/Arf gene locus in senescence
Collins, C. J., & Sedivy, J. M. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00048.x · Cited by 113
Self-citationAndreassen, P. R., Lacroix, F., Lohez, O. D., & Margolis, R. L. (2001) · PubMed · Cited by 113
Zhou, Y. F., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y. G., & Weinstein, J. N. (2002) · PubMed · Cited by 113
Cytoplasmic ASPP1 inhibits apoptosis through the control of YAPPreprint
Vigneron, A. M., Ludwig, R. L., & Vousden, K. H. (2010) · Genes & Development · doi:10.1101/gad.1954310 · Cited by 115
Persengiev, S. P., Devireddy, L. R., & Green, M. R. (2002) · Genes & Development · doi:10.1101/gad.992202 · Cited by 113
Distinct mechanisms act in concert to mediate cell cycle arrest
Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112
Zhao, S., Zhang, Y., Lu, X., Ding, H., Han, B., Song, X., Miao, H., Cui, X., Wei, S., Liu, W., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64003 · Cited by 112
The Fbw7 and BetaTRCP E3 ubiquitin ligases and their roles in tumorigenesis
Alan, W. L. (2012) · Frontiers in bioscience · doi:10.2741/4045 · Cited by 112
Día, V. P., & de Mejı́a, E. G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.02.010 · Cited by 112
Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells
Kaeser, M. D., Kaeser-Pebernard, S., & Iggo, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311732200 · Cited by 113
Mouse Submandibular Gland Morphogenesis: a Paradigm for Embryonic Signal Processing
Molnick, M., & Jaskoll, T. F. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110020401 · Cited by 112
Blagosklonny, M. V., Robey, R. W., Bates, S. E., & Fojo, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8625 · Cited by 112
Guidi, R., Guerra, L., Levi, L., Stenerlöw, B., Fox, J. G., Josenhans, C., Masucci, M. G., & Frisan, T. (2012) · Cellular Microbiology · doi:10.1111/cmi.12034 · Cited by 111
Liu, Y., Wang, W., Fang, B., Ma, F., Zheng, Q., Deng, P., Zhao, S., Chen, M., Yang, G., & He, G. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.013 · Cited by 111
DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation
Uxa, S., Bernhart, S. H., Mages, C. F., Fischer, M., Kohler, R., Hoffmann, S., Stadler, P. F., Engeland, K., & Müller, G. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz635 · Cited by 121
Yan, J., Chen, J., Zhang, N., Yang, Y., Zhu, W., Li, L., & He, B. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02266j · Cited by 111
Gene targeting and somatic cell genetics: a rebirth or a coming of age?
Sedivy, J. M., & Dutriaux, A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01689-8 · Cited by 111
Self-citationEstève, P., Chin, H. G., & Pradhan, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606203200 · Cited by 111
Exposure to ultraviolet radiation causes apoptosis in developing sea urchin embryos
Lesser, M. P., Kruse, V. A., & Barry, T. M. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00621 · Cited by 111
Telomeric Protein Pin2/TRF1 as an Important ATM Target in Response to Double Strand DNA Breaks
Kishi, S., Zhou, X. Z., Ziv, Y., Khoo, C., HILL, D. E., Shiloh, Y., & Lu, K. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011534200 · Cited by 116
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
p53-mediated apoptosis requires inositol hexakisphosphate kinase-2
Koldobskiy, M. A., Chakraborty, A., Werner, J. K., Snowman, A. M., Juluri, K. R., Vandiver, M. S., Kim, S., Heletz, S., & Snyder, S. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015671107 · Cited by 112
Metadata
- Authors
- Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
- Corresponding author
- Vogelstein, B.
- Venue
- Science
- Published
- 1998-11-20
- Volume
- 282
- Issue
- 5393
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080125477
- Cited by
- 2,803
- References
- 50
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
- FWCI
- 41.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
- MeSH terms
- Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review